Joint Documents

Blood Bag Identification Using ISBT 128 and GS1

JP-003 Blood Bag Identification Using ISBT 128 and GS1 v1.0.1 – PDF

This document is intended to provide guidance to blood bag manufacturers, their customers, and software developers on the bar coding of blood bags and their shipping containers. It deals with the relationship between information held in the GS1 carton codes and the ISBT 128 blood container label codes, and recommends ways to simplify the mapping between this information.


Assigning a Patient Identification Number

JP-004 Assigning a Patient Identification Number v1.0.0 – PDF

This document visits two mechanisms for assigning patient identification numbers – a globally unique option using the GS1 Global Service Relation Number (GSRN) and a locally assigned number using the ISBT 128 data structure.


Consensus Statement on Terminology Coding and Labeling of Cellular Therapy Products

JP-005 Consensus Statement on Terminology Coding and Labeling of Cellular Therapy Products - v1.0.1 - PDF

The Boards of the organizations listed below:

  • reaffirm their endorsement of ISBT 128 as the global standard for the terminology, coding and labeling of cellular therapy products, including those prepared via a cell therapy manufacturing process;
  • encourage the international adoption of ISBT 128 standard terminology to describe cellular therapy products throughout the pre-clinical, translational, and clinical research stages and through to clinical use
  • encourage the use of this terminology throughout the scientific literature when describing cellular therapy products; and,
  • encourage other relevant professional bodies, accreditation bodies, regulators, and health authorities to support this ongoing drive for global standardization.

This statement is supported by: AABB, APBMT, ASFA, ASTCT, Be The Match (NMDP), EBMT, EMBMT, FACT, ICCBBA, ISBT, ISCT, JACIE, LABMT, WBMT, and WMDA.

Please contact ICCBBA if you would like your society to be added to the list of supporting organizations. 


GS1 and ICCBBA - Medical Devices and Biologics

GS1 and ICCBBA Guidance: Identification of medical devices containing an HCT/P in the United States  PDF

This guidance document applies to the identification of human cells, tissues and cellular and tissue-based products (HCT/Ps) that are regulated as medical devices using a Unique Device Identifier (UDI) as required under the US Food and Drug Administration’s (FDA’s) Unique Device Identification System Final Rule (78 FR 58785; September 24, 2013).

The rationale that applies to the use of ISBT 128 for tissues regulated as medical devices applies equally to its use for traditional tissues. Therefore, ICCBBA also encourages the use of ISBT 128 for tissues regulated as biologics to provide a consistent means of coding all tissue for transplantation.   

GS1 and ICCBBA, working within the terms of an existing Memorandum of Understanding, have developed this document to clarify the appropriate use of the GS1 and ISBT 128 unique device identifiers, and the interfaces between the standards.


GS1 and ICCBBA - Plasma Derivatives

Bar Coding Plasma Derivatives, Implementation Guide, Issue #1.0 – PDF

ISBT 128 defines Plasma Derivatives as, "A product that contains concentrated fractions of plasma proteins that have been separated using physico-chemical or other fractionation processes. It is made from pooling plasma from large numbers of donors and is traced based on the lot or batch number of the pooled product.”

It is recommended that those products for which ABO blood groups is not relevant (e.g., Rh Immune Globulin or Gamma Globulin) be labeled with GS1 bar codes. Conversely, plasma derivatives for which the ABO blood group is relevant should be labeled with ISBT 128.